menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

2 22
20.12.2024
Shares in Novo Nordisk plunged 20% on Friday.

© Fortune

Get it on Google Play